Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 52

1.

Mass spectrometry profiling of oxysterols in human sperm identifies 25-hydroxycholesterol as a marker of sperm function.

Zerbinati C, Caponecchia L, Puca R, Ciacciarelli M, Salacone P, Sebastianelli A, Pastore A, Palleschi G, Petrozza V, Porta N, Rago R, Carbone A, Iuliano L.

Redox Biol. 2017 Apr;11:111-117. doi: 10.1016/j.redox.2016.11.008. Epub 2016 Nov 22.

2.
3.

Extra-virgin olive oil phenols block cell cycle progression and modulate chemotherapeutic toxicity in bladder cancer cells.

Coccia A, Mosca L, Puca R, Mangino G, Rossi A, Lendaro E.

Oncol Rep. 2016 Dec;36(6):3095-3104. doi: 10.3892/or.2016.5150. Epub 2016 Oct 5.

4.

A case of figurate urticaria by etanercept.

Sessa M, Sullo MG, Mascolo A, Cimmaruta D, Romano F, Puca RV, Capuano A, Rossi F, Schiavo AL.

J Pharmacol Pharmacother. 2016 Apr-Jun;7(2):106-8. doi: 10.4103/0976-500X.184777.

5.

Peribiliary Glands as a Niche of Extrapancreatic Precursors Yielding Insulin-Producing Cells in Experimental and Human Diabetes.

Carpino G, Puca R, Cardinale V, Renzi A, Scafetta G, Nevi L, Rossi M, Berloco PB, Ginanni Corradini S, Reid LM, Maroder M, Gaudio E, Alvaro D.

Stem Cells. 2016 May;34(5):1332-42. doi: 10.1002/stem.2311. Epub 2016 Feb 26.

6.

Adult Human Biliary Tree Stem Cells Differentiate to β-Pancreatic Islet Cells by Treatment with a Recombinant Human Pdx1 Peptide.

Cardinale V, Puca R, Carpino G, Scafetta G, Renzi A, De Canio M, Sicilia F, Nevi L, Casa D, Panetta R, Berloco PB, Reid LM, Federici G, Gaudio E, Maroder M, Alvaro D.

PLoS One. 2015 Aug 7;10(8):e0134677. doi: 10.1371/journal.pone.0134677. eCollection 2015.

7.

Pemphigus erythematosus relapse associated with atorvastatin intake.

Lo Schiavo A, Puca RV, Romano F, Cozzi R.

Drug Des Devel Ther. 2014 Sep 18;8:1463-5. doi: 10.2147/DDDT.S66666. eCollection 2014.

8.

Influence of Egr-1 in cardiac tissue-derived mesenchymal stem cells in response to glucose variations.

Bastianelli D, Siciliano C, Puca R, Coccia A, Murdoch C, Bordin A, Mangino G, Pompilio G, Calogero A, De Falco E.

Biomed Res Int. 2014;2014:254793. doi: 10.1155/2014/254793. Epub 2014 May 22.

9.

The transcription factor EGR1 localizes to the nucleolus and is linked to suppression of ribosomal precursor synthesis.

Ponti D, Bellenchi GC, Puca R, Bastianelli D, Maroder M, Ragona G, Roussel P, Thiry M, Mercola D, Calogero A.

PLoS One. 2014 May 1;9(5):e96037. doi: 10.1371/journal.pone.0096037. eCollection 2014.

10.

Axitinib affects cell viability and migration of a primary foetal lung adenocarcinoma culture.

Menna C, De Falco E, Pacini L, Scafetta G, Ruggieri P, Puca R, Petrozza V, Ciccone AM, Rendina EA, Calogero A, Ibrahim M.

Cancer Invest. 2014 Jan;32(1):13-21. doi: 10.3109/07357907.2013.861472.

PMID:
24380379
11.

Suitability of human Tenon's fibroblasts as feeder cells for culturing human limbal epithelial stem cells.

Scafetta G, Tricoli E, Siciliano C, Napoletano C, Puca R, Vingolo EM, Cavallaro G, Polistena A, Frati G, De Falco E.

Stem Cell Rev. 2013 Dec;9(6):847-57. doi: 10.1007/s12015-013-9451-6.

PMID:
23832306
12.

The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.

Ruggieri P, Mangino G, Fioretti B, Catacuzzeno L, Puca R, Ponti D, Miscusi M, Franciolini F, Ragona G, Calogero A.

PLoS One. 2012;7(10):e47825. doi: 10.1371/journal.pone.0047825. Epub 2012 Oct 22.

13.

Elephantiasis nostras verrucosa: a rare case of thyroid dermopathy.

Lo Schiavo A, Caccavale S, Alfano R, Puca RV, Cozzi R.

Indian J Dermatol Venereol Leprol. 2012 Sep-Oct;78(5):650-2. doi: 10.4103/0378-6323.100578. No abstract available.

14.

A standardized laboratory and surgical method for in vitro culture isolation and expansion of primary human Tenon's fibroblasts.

De Falco E, Scafetta G, Napoletano C, Puca R, Vingolo EM, Ragona G, Iorio O, Frati G.

Cell Tissue Bank. 2013 Jun;14(2):277-87. doi: 10.1007/s10561-012-9325-1. Epub 2012 Jul 21.

PMID:
22820760
15.

Etanercept in the treatment of generalized annular pustular psoriasis.

Lo Schiavo A, Brancaccio G, Puca RV, Caccavale S.

Ann Dermatol. 2012 May;24(2):233-4. doi: 10.5021/ad.2012.24.2.233. Epub 2012 Apr 26. No abstract available.

16.

Zinc supplementation augments in vivo antitumor effect of chemotherapy by restoring p53 function.

Margalit O, Simon AJ, Yakubov E, Puca R, Yosepovich A, Avivi C, Jacob-Hirsch J, Gelernter I, Harmelin A, Barshack I, Rechavi G, D'Orazi G, Givol D, Amariglio N.

Int J Cancer. 2012 Aug 15;131(4):E562-8. doi: 10.1002/ijc.26441. Epub 2011 Nov 30.

17.

Restoring p53 active conformation by zinc increases the response of mutant p53 tumor cells to anticancer drugs.

Puca R, Nardinocchi L, Porru M, Simon AJ, Rechavi G, Leonetti C, Givol D, D'Orazi G.

Cell Cycle. 2011 May 15;10(10):1679-89. Epub 2011 May 15.

PMID:
21508668
18.

HIF-1α antagonizes p53-mediated apoptosis by triggering HIPK2 degradation.

Nardinocchi L, Puca R, D'Orazi G.

Aging (Albany NY). 2011 Jan;3(1):33-43.

19.

Zinc downregulates HIF-1α and inhibits its activity in tumor cells in vitro and in vivo.

Nardinocchi L, Pantisano V, Puca R, Porru M, Aiello A, Grasselli A, Leonetti C, Safran M, Rechavi G, Givol D, Farsetti A, D'Orazi G.

PLoS One. 2010 Dec 13;5(12):e15048. doi: 10.1371/journal.pone.0015048.

20.

Counteracting MDM2-induced HIPK2 downregulation restores HIPK2/p53 apoptotic signaling in cancer cells.

Nardinocchi L, Puca R, Givol D, D'Orazi G.

FEBS Lett. 2010 Oct 8;584(19):4253-8. doi: 10.1016/j.febslet.2010.09.018. Epub 2010 Sep 16.

21.

Adjuvant drugs in autoimmune bullous diseases, efficacy versus safety: Facts and controversies.

Schiavo AL, Puca RV, Ruocco V, Ruocco E.

Clin Dermatol. 2010 May-Jun;28(3):337-43. doi: 10.1016/j.clindermatol.2009.06.018.

PMID:
20541689
22.

Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.

Puca R, Nardinocchi L, Givol D, D'Orazi G.

Oncogene. 2010 Aug 5;29(31):4378-87. doi: 10.1038/onc.2010.183. Epub 2010 May 31. Review.

PMID:
20514025
23.

Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival.

Lanni C, Nardinocchi L, Puca R, Stanga S, Uberti D, Memo M, Govoni S, D'Orazi G, Racchi M.

PLoS One. 2010 Apr 14;5(4):e10171. doi: 10.1371/journal.pone.0010171.

24.

HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition.

Nardinocchi L, Puca R, Givol D, D'Orazi G.

Cell Cycle. 2010 Apr 1;9(7):1270-5. Review.

PMID:
20234185
25.

Nox1 is involved in p53 deacetylation and suppression of its transcriptional activity and apoptosis.

Puca R, Nardinocchi L, Starace G, Rechavi G, Sacchi A, Givol D, D'Orazi G.

Free Radic Biol Med. 2010 May 15;48(10):1338-46. doi: 10.1016/j.freeradbiomed.2010.02.015. Epub 2010 Feb 18.

PMID:
20171273
26.

Interaction of p53 with Mdm2 and azurin as studied by atomic force spectroscopy.

Funari G, Domenici F, Nardinocchi L, Puca R, D'Orazi G, Bizzarri AR, Cannistraro S.

J Mol Recognit. 2010 Jul-Aug;23(4):343-51. doi: 10.1002/jmr.999.

PMID:
19941302
27.

HIPK2 modulates p53 activity towards pro-apoptotic transcription.

Puca R, Nardinocchi L, Sacchi A, Rechavi G, Givol D, D'Orazi G.

Mol Cancer. 2009 Oct 14;8:85. doi: 10.1186/1476-4598-8-85.

28.

Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.

Nardinocchi L, Puca R, Sacchi A, Rechavi G, Givol D, D'Orazi G.

PLoS One. 2009 Aug 28;4(8):e6819. doi: 10.1371/journal.pone.0006819.

29.

The immunocompromised district: a unifying concept for lymphoedematous, herpes-infected and otherwise damaged sites.

Ruocco V, Brunetti G, Puca RV, Ruocco E.

J Eur Acad Dermatol Venereol. 2009 Dec;23(12):1364-73. doi: 10.1111/j.1468-3083.2009.03345.x. Epub 2009 Jun 22. Review.

PMID:
19548975
30.

Pemphigus relapse and acetazolamide, a drug with an active amide group: a casual or causal relationship?

Lo Schiavo A, Sangiuliano S, Puca RV, Brunetti G, Ruocco E.

J Eur Acad Dermatol Venereol. 2009 Jun;23(6):716-7. doi: 10.1111/j.1468-3083.2009.03170.x. No abstract available.

PMID:
19470051
31.

Pemphigus and drug addiction.

Puca RV, Ruocco E, Lo Schiavo A.

J Eur Acad Dermatol Venereol. 2009 Aug;23(8):958. doi: 10.1111/j.1468-3083.2009.03146.x. Epub 2009 May 26. No abstract available.

PMID:
19298488
32.
33.

Cefuroxime-induced pemphigus erythematosus in a young boy.

Baroni A, Puca RV, Aiello FS, Palla M, Faccenda F, Vozza G, Sangiuliano S, Ruocco E.

Clin Exp Dermatol. 2009 Aug;34(6):708-10. doi: 10.1111/j.1365-2230.2008.03007.x. Epub 2008 Dec 9.

PMID:
19077088
34.

Transcriptional regulation of hypoxia-inducible factor 1alpha by HIPK2 suggests a novel mechanism to restrain tumor growth.

Nardinocchi L, Puca R, Guidolin D, Belloni AS, Bossi G, Michiels C, Sacchi A, Onisto M, D'Orazi G.

Biochim Biophys Acta. 2009 Feb;1793(2):368-77. doi: 10.1016/j.bbamcr.2008.10.013. Epub 2008 Nov 6.

35.

Restoring wtp53 activity in HIPK2 depleted MCF7 cells by modulating metallothionein and zinc.

Puca R, Nardinocchi L, Bossi G, Sacchi A, Rechavi G, Givol D, D'Orazi G.

Exp Cell Res. 2009 Jan 1;315(1):67-75. doi: 10.1016/j.yexcr.2008.10.018. Epub 2008 Oct 28.

PMID:
18996371
36.

Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2.

Puca R, Nardinocchi L, D'Orazi G.

J Exp Clin Cancer Res. 2008 Jul 21;27:22. doi: 10.1186/1756-9966-27-22.

37.

Contact pemphigus: a side-effect of imiquimod therapy.

Lo Schiavo A, Sangiuliano S, Puca RV, Brunetti G, Ruocco E, Cozzi R.

Int J Dermatol. 2008 Jul;47(7):765-7. doi: 10.1111/j.1365-4632.2008.03533.x. No abstract available.

PMID:
18613893
38.

Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown.

Puca R, Nardinocchi L, Gal H, Rechavi G, Amariglio N, Domany E, Notterman DA, Scarsella M, Leonetti C, Sacchi A, Blandino G, Givol D, D'Orazi G.

Cancer Res. 2008 May 15;68(10):3707-14. doi: 10.1158/0008-5472.CAN-07-6776.

39.

Pemphigus and chrysotherapy: all that glitters is not gold!

Lo Schiavo A, Sangiuliano S, Puca RV, Brunetti G, Ruocco E, Cozzi R.

Int J Dermatol. 2008 Jun;47(6):645-7. doi: 10.1111/j.1365-4632.2008.03530.x. No abstract available.

PMID:
18477174
40.

Overexpression of HIPK2 circumvents the blockade of apoptosis in chemoresistant ovarian cancer cells.

Puca R, Nardinocchi L, Pistritto G, D'Orazi G.

Gynecol Oncol. 2008 Jun;109(3):403-10. doi: 10.1016/j.ygyno.2008.02.018. Epub 2008 Apr 18.

PMID:
18395248
41.

Statinat-induced pemphigus: over-the-counter drugs too may be harmful!

Lo Schiavo A, Brunetti G, Puca RV, Sangiuliano S, Ruocco E.

J Eur Acad Dermatol Venereol. 2009 Jan;23(1):70-1. doi: 10.1111/j.1468-3083.2008.02664.x. Epub 2008 Apr 1. No abstract available.

PMID:
18384563
42.

Pemphigus vulgaris after coxsackievirus infection and cephalosporin treatment: a paraviral eruption?

Ruocco E, Lo Schiavo A, Baroni A, Sangiuliano S, Puca RV, Brunetti G, Ruocco V.

Dermatology. 2008;216(4):317-9. doi: 10.1159/000113944. Epub 2008 Jan 29.

PMID:
18230979
43.

HIPK2 knock-down compromises tumor cell efficiency to repair damaged DNA.

Nardinocchi L, Puca R, Sacchi A, D'Orazi G.

Biochem Biophys Res Commun. 2007 Sep 14;361(1):249-55. Epub 2007 Jul 17.

PMID:
17658469
44.

HIPK2-induced p53Ser46 phosphorylation activates the KILLER/DR5-mediated caspase-8 extrinsic apoptotic pathway.

Pistritto G, Puca R, Nardinocchi L, Sacchi A, D'Orazi G.

Cell Death Differ. 2007 Oct;14(10):1837-9. Epub 2007 Jul 13. No abstract available.

45.

Lymphedematous areas: privileged sites for tumors, infections, and immune disorders.

Ruocco E, Puca RV, Brunetti G, Schwartz RA, Ruocco V.

Int J Dermatol. 2007 Jun;46(6):662. No abstract available.

PMID:
17550576
46.

Sporotrichosis: success of itraconazole treatment.

Baroni A, Palla M, Iovene MR, Faccenda F, Aiello FS, Puca RV, Satriano RA.

Skinmed. 2007 Jan-Feb;6(1):41-4.

PMID:
17215622
47.

Individual differences in approach and avoidance movements: how the avoidance motive influences response force.

Puca RM, Rinkenauer G, Breidenstein C.

J Pers. 2006 Aug;74(4):979-1014.

PMID:
16787426
48.

Assessing achievement, affiliation, and power motives all at once: the Multi-Motive Grid (MMG).

Sokolowski K, Schmalt HD, Langens TA, Puca RM.

J Pers Assess. 2000 Feb;74(1):126-45.

PMID:
10779937
49.

[Periodontal problems connected with orthodontic treatment of impacted teeth on high or vestibular eruption].

Di Lello MT, Galeota G, Caiazzo G, Puca R.

Arch Stomatol (Napoli). 1990 Oct-Dec;31(4):775-85. Italian.

PMID:
2100488
50.

Dopaminergic mediation of the diuretic and natriuretic effects of ANF in the rat.

Webb RL, Della Puca R, Manniello J, Robson RD, Zimmerman MB, Ghai RD.

Life Sci. 1986 Jun 23;38(25):2319-27.

PMID:
2941632

Supplemental Content

Support Center